Eksipien Dalam Sediaan Cair
Eksipien Dalam Sediaan Cair
Eksipien Dalam Sediaan Cair
Pertemuan 4
Eksipien dalam Sediaan Cair
Types of Liquid Dosage Form (LDF)
• Solutions
- Aqueous solutions + Sugar Syrup
- Hydroalcoholic Elixir
- Aromatic alcoholic solutions Spirit
- Aromatic aqueous solutions Aromatic water
- Extracted liquids from crude products Tincture
• Emulsions
• Suspensions
Type of excipients
1. Solvents/Co-solvents
2. Buffering agents
3. Anti microbial preservatives
4. Anti oxidants
5. Sequestering agents
6. Wetting agents
7. Anti foaming agents
8. Thickening agents
9. Sweetening agents
10. Colouring agents
11. Flavouring agents
12. Humectant
1.Solvents/Co-Solvents
• Water is the solvent most widely used as a vehicle due to:
▫ Lack of toxicity, physiological compatibility, and good
solubilising power (high dielectric constant), but
Likely to cause instability of hydrolytically unstable drugs
Good vehicle for microbial growth
Physiological compatibility
Lack of toxicity
Possesses a high dielectric
constant
ensuring the dissolution of a wide range of
ionizable materials
Lack of selectivity
• Water is used both as vehicle and as a solvent for the
desired flavoring or medicinal ingredients.
• Advantages: Tasteless, odourless, lack of
pharmacological activity, neutral and very cheap
• Tap Water
• It is not permitted to use tap water for the dispensing of
pharmaceutical dosage forms due to its possible bacterial
contamination and the presence of dissolved salts that
destroy the active ingredients or enhance their
decomposition.
• Percentage (%)
• % w/v (e.g., 1%w/v =1g constituent in 100 mL
• %v/v (e.g., 1%v/v = 1mL constituent in 100 mL
preparation)
• % w/w (e.g.,1%w/w=1
preparation) g constituent in 100 g
preparation)
• Ratio strength
• weight in volume (e.g., 1:1000 w/v= 1g constituent in 1000
mL preparation)
• volume in volume (e.g., 1:1000 v/v = 1ml constituent in
1000 mL preparation)
• weight in weight (e.g., 1:1000 w/w = 1 g constituent in 1000
g preparation)
2. Buffering Agents
• Can be necessary to maintain pH of the formulation to:
▫ Ensure physiological compatibility
▫ Maintaining/optimising chemical stability
▫ Maintaining/optimising anti-microbial
effectiveness
▫ Optimise solubility (or insolubility if taste is an
issue)
But, optimum pH for chemical stability, preservative
effectiveness and solubility (or insolubility) may not be
the same
Compromises need to be made
• Ex: carbonates, citrates, phosphate, lactates,
gluconates, tartarates, borates (external). Its
presence in solution resists any changes in pH
upon dilution or addition of small quantities of
acid or base. The usual buffering agents used in
oral liquid preparations are acetate and
phosphate buffer. The buffer increase
3. Anti-microbial Preservatives
a. Preservatives are used in multi-use cosmetic/pharmaceutical
products (including paediatric formulations)
▫ Prevents an increased risk of contamination and proliferation by opportunistic
microbes (from excipients or introduced externally), that would result in
potential health issues
▫ Avoid use wherever possible, especially in products aimed at younger
paediatric patients
e.g. not required for sterile, single-dose products (as recommended for
neonates)
b. Ideally targeted for microbial cells - showing no toxicity/irritancy
towards mammalian cells
▫ Challenge is that the active groups involved are usually harmful to all living
tissue
c. There are a limited number of approved preservatives available for multi-
use oral products, and options are even more limited for other routes of
administration
▫ Should not use in parenteral infusions
▫ Must avoid access to cerebrospinal fluid and retro-ocular administration
d. This restricted number can be further reduced by consideration of
factors such as levels required (dose), pH-solubility profiles, API &
excipient incompatibilities, adsorption, irritancy and toxicity.
Choice of Preservative
The preservative selected should have the following
properties :
• It should be effective against a wide range of
microorganisms.
• It should be compatible with other ingredients of the
formulation.
• It should be soluble in aqueous phase when used in
emulsions.
• It should be nontoxic.
• It should be free from odour and taste.
• It should preserve the preparations and remain stable
for the shelf life of the product.
• No singly preservative possesses all the qualities
therefore it becomes necessary to use a combination of
preservatives to prevent the growth of
microorganisms. The most commonly used
preservatives are as follows:
Examples:
1. Benzoic acid and sodium benzoate 0.1 to 0.2%.
2. Salicylic acid 0.1%.
3. Phenol 0.2 to 0.5%.
4. Chlorocresol 0.05 to 0.1%.
5. Alcohol 15 t 20%.
6. Chlorbutanol 0.5%.
7. Phenylmercuric nitrate 0.002 to 0.005%.
8. Sorbic cid and its salts 0.05 to 0.2%.
9. Benzalkonium chloride 0.004 to 0.02 %.
10.Methyl paraben and propyl paraben 0.1% to 0.2%.
4. Anti-Oxidants
• Used to control oxidation of:
▫ API
▫ Preservative, e.g. potassium sorbate
▫ Vehicle, e.g. oils or fats susceptible to β-oxidation
(rancidification)
▫ Colourants (ageing discolouration)
process
Examples:
6. Wetting Agents
• To aid ‘wetting’ and dispersion of a
hydrophobic API, preservative or antioxidant
▫ Reduce interfacial tension between solid and liquid during
manufacture or reconstitution of a suspension
▫ Not all are suitable for oral administration
• Examples include:
▫ Surface active agents, e.g.
Oral: polysorbates (Tweens), sorbitan esters (Spans)
Parenteral: polysorbates, poloxamers, lecithin
External: sodium lauryl sulphate
….but these can cause excessive foaming (see anti-foaming
agents) and can lead to deflocculation and undesirable
physical instability (sedimentation) if levels too high
• Artificial sweeteners
▫ Regulatory review required – often restricted territories
▫ Much more intense sweeteners compared with sucrose
▫ As a consequence the levels are much lower (<0.2%) but still need to
refer to WHO Acceptable Daily Intakes (ADIs)
▫ Can impart a bitter or metallic after-taste (hence used in combination with
natural sweeteners), e.g.
Saccharin, and it’s salts
Aspartame
Acesulfame –K
Sucralose – excellent sweetness, non-cariogenic, low calorie,
wide & growing regulatory acceptability but relatively
expensive
10. Flavouring Agents
• Supplement and complement a sweetening agent
▫ Ensures patient compliance (especially in paediatric formulations – a big
issue)
▫ Can be natural, e.g. peppermint, lemon oils,
▫ Or artificial e.g. butterscotch, ‘tutti-frutti’ flavour
▫ Instability can be an issue – combinations can be used to cover intended
product shelf-life
• Taste appreciation is not globally consistent…
▫ Genetic element: one person’s acceptable taste is another’s unacceptable
taste
▫ Territorial (cultural?) differences in preference; e.g. US vs. Japan vs. Europe
▫ Affected by age (paediatric perception and preferences are different from
adult)
▫ Can be affected by certain disease states, e.g. during cancer chemotherapy
• Regulatory acceptability of flavours needs to be checked
▫ Different sources, different compositions, different flavour, e.g. there are >30
different “strawberry flavours”!
▫ Usually complex of composition (so refer to internationally recognised
standards)
11. Colouring agents
• The examples of mineral colours are ferric oxide (yellow and red), carbon black,
titanium dioxide and ultramarine.
• Only the permitted colours are used in food and pharmaceutical preparations.
Caramel or burnt sugar, an artificial colour is used to produce brown colour in
cough syrups. elixirs and other oral liquid preparation.
Certified color additives are classified according to
their approved use: (a) FD&C color additives,
which may be used in foods, drugs, and cosmetics;
(b) D&C color additives, some of which are
approved for use in drugs, some in cosmetics, and
some in medical devices; and (c) external D&C
color additives, the use of which is restricted to
external parts of the body, not including the lips
or any other body surface covered by mucous
membrane
12. Humectants
• Hygroscopic excipients used at ~5% in aqueous
suspensions and emulsions for external application.
• Their function is to retard evaporation of aqueous
vehicle of dosage form:
▫ To prevent drying of the product after application to the
skin
▫ To prevent drying of product from the container after first
opening
▫ To prevent cap-locking caused by condensation onto neck
of container-closure of a container after first opening
• Examples include:
▫ propylene glycol
▫ glycerol
▫ PEG
General philosophy regarding excipients for
liquid dosage forms
• Choose the appropriate dosage form for the target
population(s)
• Avoid health hazards – apply a benefit vs. risk balance
assessment:
▫ Minimum age of target population
▫ Maximum duration of therapy
▫ Double-check age-related safety of “established” (adult dosage form?)
excipients
▫ Novel excipients need comprehensive safety testing
• Justify inclusion and minimise number of excipients and
quantity to be
used:
▫ Especially
younger age
groups
▫ Choose dosage
forms that achieve
this
▫ Not for aesthetic
or cosmetic
purposes
▫ Avoid sugar for
long-term use
Overview thoughts for paediatric dosage forms
So…..
• Aspartame Toxicity
▫ Source of phenylalanine – possibly an issue for phenylketoneurics
▫ Aspartame has been blamed for hyperactivity in children but as yet
unproven
• Sorbitol
▫ Can induce diarrhoea
Solvents/Solvent sweeteners
• Need for oral liquid preparations (that
children typically find easier to swallow) often
necessitates:
▫ Taste-masking; which often relies on sweeteners
▫ Addition of co-solvents to improve drug solubility …if a solution is wanted
(elegance/mouth feel vs. taste)
▫ Significant lactose intolerance can also occur in adults but this is rare.
“E number” Additives
(Colourants, preservatives, stabilisers, anti-
oxidants, etc.)
• Current high profile concerns...
TERIMAKASIH